ESTRO meets Asia_Programme Book_2018

FRIDAY 7 DECEMBER 2018

17:03 > Initial validation of dose calculation accuracy on Hounsfield Unit-corrected pelvic cone beam CT

G. Bengua, S. Lydiard, J. Sandison, S. Andersson, R. Nilsson (New Zealand)

OC-047

PROFFERED PAPERS 2 Upper GI and thorax (Clinical) 16:15 - 17:30 | ROOM GARNET 213 Chairs: B. Slotman (The Netherlands) and I. Tham (Singapore)

16:15 > Exclusive dose-escalated chemoradiotherapy in esophageal carcinoma: a randomized phase II study G. Crehange, A. Bertaut, E. Le Prisé, P.L. Etienne, E. Rio, R. Pereira, G. Noel, K. Benezery, D. Peiffert (France) 16:25 > Retrospective study of adjuvant chemoradiotherapy for R0 resected patients with pN3 gastric cancer M.L. Zhou, Y.Q. Wang, W. Yang, M. Mo, R. Hu, Y. Wang, G.C. Li, Z.W. Long, X.W. Liu, Y.N. Wang, Z. Zhang (China)

OC-048

OC-049

16:35 > Quality of life for gemcitabine+nab-paclitaxel+SBRT vs. gemcitabine+S-1+SBRT in pancreatic cancer

X. Zhu, Y. Cao, Y. Shen, S. Qing, F. Cao, L. Gu, F. Fang, Z. Jia, X. Ju, H. Zhang (China)

OC-050

16:45 > Acute toxicity of hypofractionated radiation with simultaneous bed boost in breast cancer patients J. Luo, K. Jin, X. Wang, Z. Yang, J. Ma, X. Chen, X. Mei, X. Guo, X. Yu (China) 16:55 > Clinical outcomes of triple negative breast cancer : a single institution study S. Ibrahim, A. Arjunan, P. Balakrishnan, B.S. Mathew, R.K. Raghavan, K. Ramadas (India) 17:05 > A prognostic model for non-lung-cancer death in old patients treated with SBRT for lung cancer Y. Matsuo, T. Mitsuyoshi, T. Shintani, T. Mizowaki (Japan) 17:15 > Improving lung cancer outcome by reducing normal lung tissue toxicity Abstract withdrawn

OC-051

OC-052

OC-053

OC-054

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

29